PharmChem, Inc. (PCHM)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 638.89 Thousand | 1.26 Million | 875.3 Thousand | 2.17 Million | 1.81 Million | 1.5 Million |
| Net Income | 845.1 Thousand | 870.43 Thousand | 1.85 Million | 1.96 Million | 1.71 Million | 1.55 Million |
| Depreciation & Amortization | 170.00 | 170.00 | 170.00 | 2708.00 | 5488.00 | 5871.00 |
| Deferred income taxes | -18.51 Thousand | 136.84 Thousand | -166.86 Thousand | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -278.29 Thousand | 143.11 Thousand | -687.34 Thousand | 208.35 Thousand | 91.69 Thousand | -77.39 Thousand |
| Other non-cash items | 365.92 Thousand | -85.5 Thousand | 141.87 Thousand | 82.52 Thousand | -12.69 Thousand | 89.47 Thousand |
| Investing Cash Flow | - | - | 20 Thousand | - | - | - |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 20 Thousand | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -2.35 Million | -200.28 Thousand | -6.51 Million | -459.8 Thousand | -702.31 Thousand | -351.15 Thousand |
| Debt repayment | - | - | - | -125.45 Thousand | - | - |
| Dividends payments | -1.01 Million | - | -702.31 Thousand | -585.25 Thousand | -702.31 Thousand | -351.15 Thousand |
| Common Stock Repurchased | -1.33 Million | -200.28 Thousand | -5.81 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.00 | - | - | - | - | - |
| Accounts receivables | -57.86 Thousand | 337.2 Thousand | -271 Thousand | -57.47 Thousand | -33.21 Thousand | -40.51 Thousand |
| Accounts payables | 13.81 Thousand | -42.61 Thousand | -440.00 | -8551.00 | 1081.00 | 10.95 Thousand |
| Inventory | -231.09 Thousand | -92.83 Thousand | 7176.00 | -9862.00 | 52.97 Thousand | -31.72 Thousand |
| Other working capital | -3147.00 | -58.63 Thousand | -423.07 Thousand | 284.23 Thousand | 70.85 Thousand | -16.1 Thousand |
| Cash at beginning of period | 3.28 Million | 2.21 Million | 7.83 Million | 6.12 Million | 5.01 Million | 3.85 Million |
| Cash at end of period | 1.57 Million | 3.28 Million | 2.21 Million | 7.83 Million | 6.12 Million | 5.01 Million |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.71 Million | 1.06 Million | -5.61 Million | 1.71 Million | 1.11 Million | 1.15 Million |
| Free Cash Flow | 638.89 Thousand | 1.26 Million | 875.3 Thousand | 2.17 Million | 1.81 Million | 1.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 572.4 Thousand | 158.36 Thousand | 308.63 Thousand | 845.1 Thousand | 222.91 Thousand | 178.02 Thousand |
| Depreciation & Amortization | 42.00 | 42.00 | 44.00 | 170.00 | 42.00 | 42.00 |
| Deferred income taxes | 4171.00 | 44.36 Thousand | -48.53 Thousand | -18.51 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 134.39 Thousand | 14.31 Thousand | -127.99 Thousand | -278.29 Thousand | -18.21 Thousand | -2104.00 |
| Other non-cash items | -218.36 Thousand | -155.71 Thousand | 92.12 Thousand | 365.92 Thousand | 89.01 Thousand | 182.47 Thousand |
| Investing Cash Flow | -925.00 | -600.00 | - | - | - | - |
| Investments in PPE | -925.00 | -600.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -209.00 | -689.92 Thousand | -2.35 Million | -207.05 Thousand | -130.62 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -1.01 Million | - | - |
| Common Stock Repurchased | - | -209.00 | -713.57 Thousand | -1.33 Million | -494.6 Thousand | 180.57 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 23.64 Thousand | -1.00 | 287.54 Thousand | -311.19 Thousand |
| Accounts receivables | 19.04 Thousand | -73.73 Thousand | 88.3 Thousand | -57.86 Thousand | -33.49 Thousand | -9025.00 |
| Accounts payables | -82.42 Thousand | 101.58 Thousand | -49.67 Thousand | 13.81 Thousand | -24.96 Thousand | 2631.00 |
| Inventory | 74.82 Thousand | 141.19 Thousand | -97.39 Thousand | -231.09 Thousand | -11.16 Thousand | -157.51 Thousand |
| Other working capital | 122.95 Thousand | -154.72 Thousand | -98.4 Thousand | -3147.00 | 51.4 Thousand | 161.8 Thousand |
| Cash at beginning of period | 1.8 Million | 1.57 Million | 2.09 Million | 3.28 Million | 2.07 Million | 2.01 Million |
| Cash at end of period | 2.3 Million | 1.8 Million | 1.57 Million | 1.57 Million | 2.09 Million | 2.07 Million |
| Capital Expenditure | -925.00 | -600.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 503.08 Thousand | 229.52 Thousand | -524.49 Thousand | -1.71 Million | 16.99 Thousand | 63.82 Thousand |
| Free Cash Flow | 503.08 Thousand | 229.73 Thousand | 165.42 Thousand | 638.89 Thousand | 224.05 Thousand | 194.44 Thousand |
AIRJW
SKMEGGPROD
LYKALABS
BMED
NGEX
300232